Interleukin-2 modulates the responsiveness to angiotensin II in cultured vascular smooth muscle cells

Atherosclerosis

Volumn 133, Issue 1, 1997, Pages 23-30

  Nabata, Takashi ^a   Fukuo, Keisuke ^a   Morimoto, Shigeto ^a   Kitano, Shoichi ^a   Momose, Naoko ^a   Hirotani, Atsushi ^a   Nakahashi, Takeshi ^a   Nishibe, Akira ^a   Hata, Shigeki ^a   Niinobu, Tadaaki ^a   Suhara, Toshimitsu ^a   Shimizu, Masumi ^a   Ohkuma, Hiroshi ^a   Sakurai, Shoroku ^a   Nishimaki, Hiroyuki ^a   Ogihara, Toshio ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Angiotensin II; Ca2+ influx; Glycosaminoglycan; Interleukin 2; Prostacyclin; Tyrosine kinase; Vascular smooth muscle

Indexed keywords

ANGIOTENSIN; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; GENISTEIN; GLYCOSAMINOGLYCAN; INTERLEUKIN 2; NEUTRALIZING ANTIBODY; PROSTACYCLIN; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL CULTURE; DNA SYNTHESIS; ENZYME INHIBITION; EXTRACELLULAR CALCIUM; FEMALE; MUSCLE CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE;

EID: 0030860208     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00107-X     Document Type: Article

References (49)

1. Emeson EE, Robertson AL. T lymphocytes in aortic and coronary intimas. Their potential role in atherogenesis. Am J Pathol 1988;130:369.
2. Hansson GK, Holm J, Jonasson L. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am J Pathol 1989;135:169.
3. Hansson GK. Immune and inflammatory mechanisms in the development of atherosclerosis. Br Heart J 1993;69(suppl):S38.
4. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801.
5. Geng YJ, Hansson GK Interferon-γ inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages. J Clin Invest 1992;89:1322.
6. Hansson GK, Jonasson L, Holm J, Clowes MM, Clowes AW. γ-Interferon regulates vascular smooth muscle proliferation and Ia antigen expression in vivo and in vitro. Circ Res 1988;63:712.
7. Hansson GK, Holm J, Jonasson L. Interferon-γ inhibits arterial stenosis after injury. Circulation 1991;84:1266.
8. Rosenberg SA, Lotze MT, Yang JC, Topalian SL, Chang AE. Prospective randomized trial of high-dose interleukin-2 alone or in conjunction with lymphokine-activated killer cells for the treatment of patients with advanced cancer. J Natl Cancer Inst 1993;85:622.
9. Nora R, Abram JS, Tait NS, Hiponia DJ, Silverman HJ. Myocardial toxic effects during recombinant interleukin-2 therapy. J Natl Cancer Inst 1989;81:59.
10. Serneri GN, Abbate R, Gorri AM, et al. Transient intermittent lymphocyte activation is responsible for the instability of angina. Circulation 1992;86:790.
11. Blum A, Sclarovsky S, Shohat B. T lymphocyte activation in stable angina pectoris and after percutaneous transluminal coronary angioplasty. Circulation 1995;91:20.
12. Pitt B. Angiotensin-converting enzyme inhibitors in patients with coronary atherosclerosis. Am Heart J 1994;128:1328.
13. Vaughan DE, Lazos SA, Tong K. Angiotensin II regulates the expression of plasminogen activator inhibitor-1 cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis. J Clin Invest 1995;95:995.
14. Ross R. The smooth muscle cells. II. Growth of smooth muscle in culture and formation of elastic fibers. J Cell Biol 1971;50:172.
15. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985;260:3440.
16. Fukuo K, Takigawa M, Tajima K, Enomoto M, Kumahara Y, Suzuki F. Comparison of inhibition by tumor promoter (12-O-tetradecanoyl-phorbol-13-acetate) of expression of the differentiated phenotype of chondrocytes in rabbit costar chondrocytes in culture with inhibition by retinoic acid. J Biochem 1986;99:385-96.
17. Ohya Y, Sperelakis N. Involvement of a GTP-binding protein in stimulating action of angiotensin II on calcium channels in vascular smooth muscle cells. Circ Res 1991;68:763.
18. Murphy TJ, Alexander RW, Griendling KK, Runge MS, Bernstein KE. Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature 1991;351:233-6.
19. Wijetunge S, Aalkjaer C, Schachter M, Hughes AD. Tyrosine kinase inhibitors block calcium channel currents in vascular smooth muscle cells. Biochem Biophs Res Commun 1992;189:1620.
20. 2+ in rabbit isolated ear artery by platelet-derived growth factor. Br J Pharmacol 1995;114:138.
21. Rane SG, Pollock JD. Fibroblast growth factor-induced increases in calcium currents in the PC12 pheochromocytoma cell line are tyrosine phosphorylation dependent. J Neurosci Res 1994;38:590.
22. Selinfreund RH, Blair LAC. Insulin-like growth factor-1 induces a rapid increase in calcium currents and spontaneous membrane activity in clonal pituitary cells. Mol Pharmacol 1994;45:1215.
23. Hirata K, Kikuchi A, Sasaki T, et al. Involvement of rho p21 in the GTP-enhanced calcium ion sensitivity of smooth muscle contraction. J Biol Chem 1992;267:8719.
24. Satoh S, Rensland H, Pfitzer G. Ras proteins increase Ca(2 + )-responsiveness of smooth muscle contraction. FEBS Lett 1993;324:211.
25. Taniguchi T, Minami Y. The IL-2/IL-2 receptor system: a current overview. Cell 1993;73:5.
26. Graves JD, Downward J, Izquierdo-Pastor M, Rayter S, Warne PH, Cantrell DA. The growth factor IL-2 activates p21ras proteins in normal human T lymphocytes. J Immunol 1992;148:2417.
27. Berridge MJ. Inositol trisphosphate and calcium signaling. Nature 1993;361:315-25.
28. 0 and progression in S phase. Mol Biol Cell 1993;4:293-302.
29. Mohammadi M, Dionne CA, Li W, et al. Point mutation in FGF receptor eliminates phosphatidylinositol hydrolysis without affecting mitogenesis. Nature 1992;358:681-4.
30. 2+ flux but not mitogenesis. Nature 1992;358:678-81.
31. Linseman DA, Benjamin CW, Jones DA. Convergence of angiotensin II and platelet-derived growth factor receptor signaling cascade in vascular smooth muscle cells. J Biol Chem 1995;270:12563.
32. Nishida E, Gotoh Y. The MAP kinase cascade is essential for diverse signaling pathways. Trends Biochem Sci 1993;18:128.
33. Ruderman JV. MAP kinase and the activation of quiescent cells. Curr Opin Cell Biol 1993;5:207.
34. Edwards DR. Cell signaling and the control of gene transcription. Trends Pharmacol Sci 1994;15:239.
35. Watson MH, Venance SL, Pang SC, Mak AS. Smooth muscle cell proliferation: expression and kinase activities of p34cdc2 and mitogen-activated protein kinase homologues. Circ Res 1993;73:109.
36. Johnson NL, Gardner AM, Diener KM, et al. Signal transduction pathways regulated by mitogen-activated/extracellular response kinase kinase kinase induce cell death. J Biol Chem 1996;271:3229.
37. 2+-induced regulation of ion channel and MAP kinase functions. Nature 1995;376:737.
38. Tsuda T, Kawahara Y, Ishida Y, Koide M, Shii K, Yokoyama J. M., Angiotensin II stimulates two myelin basic protein/microtubule-associated protein 2 kinases in cultured vascular smooth muscle cells. Circ Res 1992;71:620.
39. Duff JL, Berk BC, Corson MA. Angiotensin II stimulates the pp44 and pp42 mitogen-activated protein kinases in cultured rat aortic smooth muscle cells. Biochem Biophys Res Commun 1992;188:257.
40. Gibbons GH, Pratt RE, Dzau VJ. Vascular smooth muscle cell hypertrophy vs. hyperplasia. J Clin Invest 1992;90:456.
41. Naftilan AJ, Pratt RE, Dzau VJ. Induction of platelet-derived growth factor A-chain and c-myc gene expression by angiotensin II in cultured vascular smooth muscle cells. J Clin Invest 1989;83:1419.
42. Temizer DH, Yoshizumi M, Perrella M, Susanni EE, Quertermous T, Lee M-E. Induction of heparin-binding epidermal growth factor-like growth factor mRNA by phorbol ester and angiotensin II in rat aortic smooth muscle cells. J Biol Chem 1992;267:24892.
43. Weber H, Taylor DS, Molloy CJ. Angiotensin II induces delayed mitogenesis and cellular proliferation in rat aortic smooth muscle cells. Correlation with the expression of specific endogenous growth factors and reversal by suramin. J Clin Invest 1994;93:788.
44. Higashiyama S, Abraham JA, Miller J, Fiddes JC, Klagsbrun M. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 1991;251:936.
45. Chakrabarti B, Park JW. Glycosaminoglycans: structure and function. CRC Crit Rev Biochem 1980;8:225.
46. Frasier-Scott K, Hatzakis H, Seong D, Jones CM, Wu KK. Influence of natural and recombinant interleukin 2 on endothelial cell arachidonate metabolism. Induction of de novo synthesis of prostaglandin H synthase. J Clin Invest 1988;82:1877.
47. Bruggeman AL, Pellicoro JA, Horigan EA, Klotman PE. Thromboxane and prostacyclin differentially regulate murine extracellular matrix gene expression. Kidney Int 1993;43:1219.
48. Vallotton MB, Gerber-Wicht C, Dolci W, Wuthrich RP. Interaction of vasopressin and angiotensin II in stimulation of prostacyclin synthesis in vascular smooth muscle cells. Am J Physiol 1989;257:E617.
49. Bailey WL, LaFleur DW, Forrester JS, Fagin JA, Sharifi BG. Stimulation of rat smooth muscle cell glycosaminoglycan production by angiotensin II. Atherosclerosis 1994;111:55.